World / Science & Health Dec 9, 2020
Testing times: More work needed on AstraZeneca/Oxford vaccine trials
by Kate Kelland
A Lancet study gave few extra clues about why efficacy was 62% for trial participants given two full doses, but 90% for a smaller subgroup given a half, then a full dose.
